p.30 抽出テキスト

Arnett et al 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Circulation. 2019;140:e596–e646. DOI: 10.1161/CIR.0000000000000678 September 10, 2019 e625 CLINICAL STATEMENTS AND GUIDELINES

S2.1-5.	 Proia KK, Thota AB, Njie GJ, et al. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47:86–99. S2.1-6.	 Chen Z, Ernst ME, Ardery G, et al. Physician-pharmacist co-management and 24-hour blood pressure control. J Clin Hypertens (Greenwich). 2013;15:337–43. S2.1-7.	 Hirsch JD, Steers N, Adler DS, et al. Primary care-based, pharmacistphysician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial. Clin Ther. 2014;36:1244–54. S2.1-8.	 Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med. 2008;23:1966–72. S2.1-9.	 Isetts BJ, Buffington DE, Carter BL, et al. Evaluation of pharmacists’ work in a physician-pharmacist collaborative model for the management of hypertension. Pharmacotherapy. 2016;36:374–84. S2.1-10.	 McLean DL, McAlister FA, Johnson JA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008;168:2355–61. S2.1-11.	 Polgreen LA, Han J, Carter BL, et al. Cost-effectiveness of a physician-pharmacist collaboration intervention to improve blood pressure control. Hypertension. 2015;66:1145–51. S2.1-12.	 Chen EH, Thom DH, Hessler DM, et al. Using the Teamlet Model to improve chronic care in an academic primary care practice. J Gen Intern Med. 2010;25 suppl 4:S610–4. S2.1-13.	 Kravetz JD, Walsh RF. Team-based hypertension management to improve blood pressure control. J Prim Care Community Health. 2016;7:272–5. S2.1-14.	 Wan EYF, Fung CSC, Jiao27 FF, et al. Five-year effectiveness of the Multidisciplinary Risk Assessment and Management Programme- Diabetes Mellitus (RAMP-DM) on diabetes-related complications and health service uses—a population-based and propensity-matched cohort study. Diabetes Care. 2018;41:49–59. S2.1-15.	 Buhse S, Mühlhauser I, Heller T, et al. Informed shared decision-making programme on the prevention of myocardial infarction in type 2 diabetes: a randomised controlled trial. BMJ Open. 2015;5:e009116. S2.1-16.	 Cooper LA, Roter DL, Carson KA, et al. A randomized trial to improve patient-centered care and hypertension control in underserved primary care patients. J Gen Intern Med. 2011;26:1297–304. S2.1-17.	 Olomu A, Hart-Davidson W, Luo Z, et al. Implementing shared decision making in federally qualified health centers, a quasi-experimental design study: the Office-Guidelines Applied to Practice (Office-GAP) program. BMC Health S24erv Res. 2016;16:334. S2.1-18.	 Parchman ML, Zeber JE, Palmer RF. Participatory decision making, patient activation, medication adherence, and intermediate clinical outcomes in type 2 diabetes: a STARNet study. Ann Fam Med. 2010;8:410–7. S2.1-19.	 Havranek EP, Mujahid MS, Barr DA, et al. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2015;132:873–98. S2.1-20.	 Vilhelmsson A, Östergren P-O. Reducing health inequalities with interventions targeting behavioral factors among individuals with low levels of education—a rapid review. PLoS ONE. 2018;13:e0195774. S2.1-21.	 Schultz WM, Kelli HM, Lisko JC, et al. Socioeconomic status and cardiovascular outcomes: challenges and interventions. Circulation. 2018;137:2166–78. S2.1-22.	 Backholer K, Peters SAE, Bots SH, et al. Sex differences in the relationship between socioeconomic status and cardiovascular disease: a systematic review and meta-analysis. J Epidemiol Community Health. 2017;71:550–7. S2.1-23.	 Beauchamp A, Peeters A, Tonkin A, et al. Best practice for prevention and treatment of cardiovascular disease through an equity lens: a review. Eur J Cardiovasc Prev Rehabil. 2010;17:599–606. S2.1-24.	 Khaing W, Vallibhakara SA, Attia J, et al. Effects of education and income on cardiovascular outcomes: a systematic review and metaanalysis. Eur J Prev Cardiol. 2017;24:1032–42. S2.1-25.	 Pollitt RA, Rose KM, Kaufman JS. Evaluating the evidence for models of life course socioeconomic factors and cardiovascular outcomes: a systematic review. BMC Public Health. 2005;5:7. S2.1-26.	 Schottenfeld L, Petersen D, Peikes D, et al. Creating Patient-centered

Team-based Primary Care. AHRQ Publication No. 16-0002-EF. 2016, Agency for Healthcare Research and Quality, US Department of Health and Human Services: Rockville, MD. Available at: https:// pcmh.ahrq.gov/page/creating-patient-centered-team-based-primary-care. Accessed January 3, 2019. S2.1-27.	 Brush JE Jr, Handberg EM, Biga C, et al. 2015 ACC health policy

statement on cardiovascular team-based care and the role of advanced practice providers. J Am Coll Cardiol. 2015;65:2118–36. S2.1-28.	 Fentanes E, Vande Hei AG, Holuby RS, et al. Treatment in a preventive cardiology clinic utilizing advanced practice providers effectively closes atherosclerotic cardiovascular disease risk-management gaps among a primary-prevention population compared with a propensity-matched primary-care cohort: a team-based care model and its impact on lipid and blood pressure management. Clin Cardiol. 2018;41:817–24. S2.1-29.	 Billioux A, Verlander K, Anthony S, et al. Standardized Screening for Health-Related Social Needs in Clinical Settings: The Accountable Health Communities Screening Tool. Available at: https://nam.edu/ wp-content/uploads/2017/05/Standardized-Screening-for-Health- Related-Social-Needs-in-Clinical-Settings.pdf. Accessed January 5, 2019. S2.1-30.	 Malambo P, Kengne AP, De Villiers A, et al. Built environment, selected risk factors and major cardiovascular disease outcomes: a systematic review. PLoS ONE. 2016;11:e0166846. S2.1-31.	 DeFilippis AP, Young R, McEvoy JW, et al. Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association- American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort. Eur Heart J. 2017;38:598–608. S2.1-32.	 Berkowitz SA, Hulberg AC, Standish S, et al. Addressing unmet basic resource needs as part of chronic cardiometabolic disease management. JAMA Intern Med. 2017;177:244–52. S2.1-33.	 Carnethon MR, Pu J, Howard G, et al. Cardiovascular health in African Americans: a scientific statement from the American Heart Association. Circulation. 2017;136:e393–423. S2.1-34.	 Rodriguez CJ, Allison M, Daviglus ML, et al. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130:593–625. S2.1-35.	 Volgman AS, Palaniappan LS, Aggarwal NT, et al. Atherosclerotic cardiovascular disease in South Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association. Circulation. 2018;138:e1–34. S2.1-36.	 Magnani JW, Mujahid MS, Aronow HD, et al. Health literacy and cardiovascular disease: fundamental relevance to primary and secondary prevention: a scientific statement from the American Heart Association. Circulation. 2018;138:e48–74. S2.1-37.	 Powell TM, de Lemos JA, Banks K, et al. Body size misperception: a novel determinant in the obesity epidemic. Arch Intern Med. 2010;170:1695–7. S2.1-38.	 Padgett J, Biro FM. Different shapes in different cultures: body dissatisfaction, overweight, and obesity in African-American and caucasian females. J Pediatr Adolesc Gynecol. 2003;16:349–54. S2.1-39.	 US Department of Health and Human Services. Healthy People 2020. Washington, DC: 2010. Available at: https://www.healthypeople. gov. Accessed January 3, 2019. S2.1-40.	 Bird EL, Ige JO, Pilkington P, et al. Built and natural environment planning principles for promoting health: an umbrella review. BMC Public Health. 2018;18:930. S2.1-41.	 Kaiser P, Diez Roux AV, Mujahid M, et al. Neighborhood environments and incident hypertension in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2016;183:988–97. S2.1-42.	 Kumanyika SK, Gary TL, Lancaster KJ, et al. Achieving healthy weight in African-American communities: research perspectives and priorities. Obes Res. 2005;13:2037–47. S2.1-43.	 Grandner MA. Addressing sleep disturbances: an opportunity to prevent cardiometabolic disease? Int Rev Psychiatry. 2014;26:155–76. S2.1-44.	 Knutson KL. Sociodemographic and cultural determinants of sleep deficiency: implications for cardiometabolic disease risk. Soc Sci Med. 2013;79:7–15. S2.1-45.	 Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and metaanalysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet. 2004;363:1589–97. S2.1-46.	 Alam R, Sturt J, Lall R, et al. An updated meta-analysis to assess

the effectiveness of psychological interventions delivered by

Downloaded from http://ahajournals.org by on October 7, 2026